| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 89/08/17 | 96/07/26 | 蔡政憲 | 康清原 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.67(Q2) | 41.17 | 2.85 | 1.04% |
| 實收資本額 | 已發行普通股 | ||
| 496,269,240 | 49,626,924 | ||
| 主要經營業務 | |||
| 細胞治療再生醫療醫療大數據 | |||
| 公司網址 | |||
| bionetcorp.com | |||
訊聯(1784) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 109,307 | 88,889 | 19.7% | 23% | 754,127 | 646,256 | 16.7% |
| 2023/07 | 91,333 | 85,337 | -12.3% | 7% | 644,820 | 557,367 | 15.7% |
| 2023/06 | 104,146 | 78,168 | 2.5% | 33.2% | 553,487 | 472,030 | 17.3% |
| 2023/05 | 101,590 | 82,030 | 12.8% | 23.8% | 449,341 | 393,862 | 14.1% |
| 2023/04 | 90,090 | 82,096 | -20.2% | 9.7% | 347,751 | 311,832 | 11.5% |
| 2023/03 | 112,877 | 88,811 | 48.4% | 27.1% | 257,661 | 229,736 | 12.1% |
| 2023/02 | 76,059 | 64,194 | 10.7% | 18.5% | 144,784 | 140,925 | 2.7% |
| 2023/01 | 68,725 | 76,731 | -26.4% | -10.4% | 68,725 | 76,731 | -10.4% |
| 2022/12 | 93,416 | 77,943 | 5.8% | 19.9% | 980,495 | 920,370 | 6.5% |
| 2022/11 | 88,261 | 72,632 | 9.8% | 21.5% | 887,079 | 842,425 | 5.3% |
| 2022/10 | 80,385 | 67,499 | 11.4% | 19.1% | 798,818 | 769,793 | 3.8% |
| 2022/09 | 72,177 | 68,159 | -18.8% | 5.9% | 718,433 | 702,294 | 2.3% |
| 2022/08 | 88,889 | 74,333 | 4.2% | 19.6% | 646,256 | 634,135 | 1.9% |
| 2022/07 | 85,337 | 84,434 | 9.2% | 1.1% | 557,367 | 559,802 | -0.4% |
| 2022/06 | 78,168 | 92,189 | -4.7% | -15.2% | 472,030 | 475,368 | -0.7% |
| 2022/05 | 82,030 | 69,524 | -0.1% | 18% | 393,862 | 383,179 | 2.8% |
| 2022/04 | 82,096 | 84,125 | -7.6% | -2.4% | 311,832 | 313,655 | -0.6% |
| 2022/03 | 88,811 | 82,729 | 38.3% | 7.3% | 229,736 | 229,530 | 0.1% |
| 2022/02 | 64,194 | 68,390 | -16.3% | -6.1% | 140,925 | 146,801 | -4% |
| 2022/01 | 76,731 | 78,411 | -1.5% | -2.1% | 76,731 | 78,411 | -2.1% |
| 2021/12 | 77,943 | 82,433 | 7.3% | -5.4% | 920,370 | 807,608 | 14% |
| 2021/11 | 72,632 | 70,952 | 7.6% | 2.4% | 842,425 | 725,175 | 16.2% |
| 2021/10 | 67,499 | 65,726 | -1% | 2.7% | 769,793 | 654,223 | 17.7% |
| 2021/09 | 68,159 | 70,609 | -8.3% | -3.5% | 702,294 | 588,497 | 19.3% |
| 2021/08 | 74,333 | 63,589 | -12% | 16.9% | 634,135 | 517,888 | 22.4% |
| 2021/07 | 84,434 | 76,084 | -8.4% | 11% | 559,802 | 454,299 | 23.2% |
| 2021/06 | 92,189 | 63,274 | 32.6% | 45.7% | 475,368 | 378,215 | 25.7% |
| 2021/05 | 69,524 | 56,641 | -17.4% | 22.7% | 383,179 | 314,941 | 21.7% |
| 2021/04 | 84,125 | 63,268 | 1.7% | 33% | 313,655 | 258,300 | 21.4% |
| 2021/03 | 82,729 | 70,608 | 21% | 17.2% | 229,530 | 195,032 | 17.7% |
| 2021/02 | 68,390 | 61,994 | -12.8% | 10.3% | 146,801 | 124,424 | 18% |
| 2021/01 | 78,411 | 62,430 | -4.9% | 25.6% | 78,411 | 62,430 | 25.6% |
| 2020/12 | 82,433 | 77,938 | 16.2% | 5.8% | 807,608 | 774,455 | 4.3% |
| 2020/11 | 70,952 | 54,976 | 7.9% | 29% | 725,175 | 696,517 | 4.1% |
| 2020/10 | 65,726 | 63,737 | -6.9% | 3.1% | 654,223 | 641,541 | 2% |
| 2020/09 | 70,609 | 58,524 | 11% | 20.6% | 588,497 | 577,804 | 1.9% |
訊聯(1784) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 14.81% | 5.31% | 2020Q3 | 14.79% | 2.70% |
| 2023Q1 | -1.68% | 2.85% | 2020Q2 | -6.08% | -2.44% |
| 2022Q4 | 6.36% | 4.70% | 2020Q1 | -0.82% | 1.18% |
| 2022Q3 | 1.70% | 2.12% | 2019Q4 | 3.68% | -2.78% |
| 2022Q2 | 5.47% | -0.38% | 2019Q3 | -6.23% | 1.09% |
| 2022Q1 | 5.35% | 0.02% | 2019Q2 | 8.82% | 1.67% |
| 2021Q4 | -3.90% | -0.11% | 2019Q1 | -15.05% | -0.14% |
| 2021Q3 | -7.69% | 1.84% | 2018Q4 | 20.82% | 3.74% |
| 2021Q2 | 7.10% | 7.44% | 2018Q3 | -4.34% | 0.99% |
| 2021Q1 | 4.76% | 4.27% | 2018Q2 | 1.25% | 3.49% |
| 2020Q4 | 4.20% | 2.86% | 2018Q1 | -2.01% | 2.65% |
評論0